Patents by Inventor Tatiana LOPATINA

Tatiana LOPATINA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical carriers containing miRNAs for use in the treatment of renal cancer
    Patent number: 11395832
    Abstract: A method for treating renal cancer by administering a pharmaceutically acceptable carrier comprising a microRNA selected from the group consisting of miR-15a, miR-181b, miR-320c, miR-874 and any combination thereof is provided. In an embodiment, the pharmaceutically acceptable carrier is an extracellular vesicle (EV) derived from an adult stem cell selected from the group consisting of a mesenchymal stem cell (MSC), a non-oval human liver progenitor cell (HLSC) and an adipose stem cell (ASC).
    Type: Grant
    Filed: December 14, 2018
    Date of Patent: July 26, 2022
    Assignee: UNICYTE EV AG
    Inventors: Giovanni Camussi, Benedetta Bussolati, Tatiana Lopatina
  • PHARMACEUTICAL CARRIERS CONTAINING miRNAs FOR USE IN THE TREATMENT OF RENAL CANCER
    Publication number: 20210069231
    Abstract: A method for treating renal cancer by administering a pharmaceutically acceptable carrier comprising a microRNA selected from the group consisting of miR-15a, miR-181b, miR-320c, miR-874 and any combination thereof is provided. In an embodiment, the pharmaceutically acceptable carrier is an extracellular vesicle (EV) derived from an adult stem cell selected from the group consisting of a mesenchymal stem cell (MSC), a non-oval human liver progenitor cell (HLSC) and an adipose stem cell (ASC).
    Type: Application
    Filed: December 14, 2018
    Publication date: March 11, 2021
    Applicant: UNICYTE EV AG
    Inventors: Giovanni CAMUSSI, Benedetta BUSSOLATI, Tatiana LOPATINA